Access the full text.
Sign up today, get DeepDyve free for 14 days.
K. Thomson, J. Hughes, J. Baeten, G. John-Stewart, C. Celum, C. Cohen, K. Ngure, J. Kiarie, N. Mugo, R. Heffron (2018)
Increased Risk of HIV Acquisition Among Women Throughout Pregnancy and During the Postpartum Period: A Prospective Per-Coital-Act Analysis Among Women With HIV-Infected PartnersThe Journal of Infectious Diseases, 218
David Rasmussen, E. Wilkinson, A. Vandormael, F. Tanser, D. Pillay, T. Stadler, T. Oliveira (2017)
External introductions helped drive and sustain the high incidence of HIV-1 in rural KwaZulu-Natal, South AfricabioRxiv
J. Molina, C. Capitant, B. Spire, G. Pialoux, L. Cotte, I. Charreau, C. Tremblay, J. Gall, E. Cua, A. Pasquet, F. Raffi, C. Pintado, C. Chidiac, J. Chas, P. Charbonneau, C. Delaugerre, M. Suzan-Monti, B. Loze, J. Fonsart, G. Peytavin, A. Chéret, J. Timsit, G. Girard, N. Lorente, M. Préau, J. Rooney, M. Wainberg, D. Thompson, W. Rozenbaum, V. Doré, L. Marchand, M. Simon, N. Etien, J. Aboulker, L. Meyer, J. Delfraissy (2015)
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection.The New England journal of medicine, 373 23
A. Grulich, R. Guy, J. Amin, F. Jin, C. Selvey, J. Holden, Heather-Marie Schmidt, I. Zablotska, K. Price, Bill Whittaker, K. Chant, C. Cooper, S. McGill, B. Telfer, B. Yeung, G. Levitt, Erin Ogilvie, N. Dharan, M. Hammoud, S. Vaccher, Lucy Watchirs-Smith, A. McNulty, David Smith, D. Allen, D. Baker, M. Bloch, Rohan Bopage, K. Brown, A. Carr, C. Carmody, Kym Collins, R. Finlayson, R. Foster, E. Jackson, D. Lewis, Josephine Lusk, C. O'Connor, N. Ryder, E. Vlahakis, P. Read, D. Cooper (2018)
Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study.The lancet. HIV, 5 11
N. Nwokolo, A. Hill, A. Mcowan, A. Pozniak (2017)
Rapidly declining HIV infection in MSM in central London.The lancet. HIV, 4 11
J. Justman, J. Reed, G. Bicego, D. Donnell, K. Li, N. Bock, A. Koler, N. Philip, C. Mlambo, B. Parekh, Y. Duong, D. Ellenberger, W. El-Sadr, R. Nkambule (2017)
Swaziland HIV Incidence Measurement Survey (SHIMS): a prospective national cohort study.The lancet. HIV, 4 2
E. Wright, A. Grulich, Katy Roy, M. Boyd, V. Cornelisse, D. Russell, D. O'Donnell, Bill Whittaker, L. Crooks, I. Zablotska (2017)
Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine HIV pre-exposure prophylaxis: clinical guidelinesJournal of Virus Eradication, 3
Paris: AIDES
London: Prepster
F. Griensven, T. Guadamuz, J. Wijngaarden, N. Phanuphak, S. Solomon, Y. Lo (2017)
Challenges and emerging opportunities for the HIV prevention, treatment and care cascade in men who have sex with men in Asia PacificSexually Transmitted Infections, 93
Pesquisa vai comparar efeitos da PrEP importada com a nacional
(2016)
New York City Department of Health and Mental Hygiene
R. Baggaley, S. Dalal, C. Johnson, Virginia Macdonald, Ioannis Mameletzis, M. Rodolph, Carmen Figueroa, J. Samuelson, A. Verster, M. Doherty, G. Hirnschall (2016)
Beyond the 90-90-90: refocusing HIV prevention as part of the global HIV responseJournal of the International AIDS Society, 19
S. McCormack, D. Dunn, M. Desai, D. Dolling, M. Gafos, R. Gilson, A. Sullivan, A. Clarke, I. Reeves, G. Schembri, N. Mackie, C. Bowman, C. Lacey, V. Apea, M. Brady, J. Fox, Stephen Taylor, S. Antonucci, S. Khoo, J. Rooney, A. Nardone, M. Fisher, A. Mcowan, A. Phillips, Anne Johnson, B. Gazzard, O. Gill (2016)
Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trialLancet (London, England), 387
Warunee Thienkrua, F. Griensven, P. Mock, Eileen Dunne, B. Raengsakulrach, Wipas Wimonsate, N. Howteerakul, C. Ungsedhapand, Anupong Chiwarakorn, T. Holtz (2018)
Young Men Who Have Sex with Men at High Risk for HIV, Bangkok MSM Cohort Study, Thailand 2006–2014AIDS and Behavior, 22
South Africa's experience in bringing PrEP to scale for a range of populations
Medical care of people living with HIV -prevention and screening
T. Hallett, J. Baeten, R. Heffron, R. Barnabas, G. Bruyn, Í. Cremin, S. Delany, G. Garnett, G. Gray, L. Johnson, J. McIntyre, H. Rees, C. Celum (2011)
Optimal Uses of Antiretrovirals for Prevention in HIV-1 Serodiscordant Heterosexual Couples in South Africa: A Modelling StudyPLoS Medicine, 8
R. Boni, V. Veloso, B. Grinsztejn (2014)
Epidemiology of HIV in Latin America and the CaribbeanCurrent Opinion in HIV and AIDS, 9
A. Kamarulzaman, S. Reid, Amee Schwitters, L. Wiessing, N. El-Bassel, K. Dolan, B. Moazen, A. Wirtz, A. Verster, F. Altice (2016)
Prevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisonersThe Lancet, 388
(2016)
World Health Organization. Global Health Sector Strategy on HIV 2016-2021. Geneva: World Health Organization
(2016)
Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Geneva: World Health Organization
Ifla Section (2009)
GUIDELINES FOR USE
Caitlin Lam, T. Holtz, W. Leelawiwat, P. Mock, Wannee Chonwattana, Wipas Wimonsate, A. Varangrat, Warunee Thienkrua, Charles Rose, A. Chitwarakorn, M. Curlin (2016)
Subtypes and Risk Behaviors Among Incident HIV Cases in the Bangkok Men Who Have Sex with Men Cohort Study, Thailand, 2006-2014.AIDS research and human retroviruses, 33 10
Dawn Smith, R. Grant, P. Weidle, A. Lansky, J. Mermin, Kevin Fenton (2011)
Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men.MMWR. Morbidity and mortality weekly report, 60 3
L. Bekker, K. Rebe, B. Brown, P. Budnik, G. Swardt, Z. Duby, N. Geffen, Brian Kanyemba, J. McIntyre, L. Myer, A. Scheibe, Laurie Schowalter, M. Sonderup, W. Spearman, C. Toledo, T. Tucker, Reon Dyk, G. Zyl (2012)
Southern African guidelines for the safe use of pre-exposure prophylaxis in men who have sex with men who are at risk for HIV infection : guidelinesSouthern African Journal of Hiv Medicine, 13
Susan Kim, S. Becker, C. Dieffenbach, B. Hanewall, C. Hankins, Y. Lo, J. Mellors, K. O'reilly, L. Paxton, Jason Roffenbender, M. Warren, P. Piot, M. Dybul (2010)
Planning for pre-exposure prophylaxis to prevent HIV transmission: challenges and opportunitiesJournal of the International AIDS Society, 13
S. Hosek, R. Landovitz, B. Kapogiannis, G. Siberry, B. Rudy, B. Rutledge, Nancy Liu, D. Harris, K. Mulligan, G. Zimet, K. Mayer, P. Anderson, J. Kiser, Michelle Lally, J. Brothers, Kelly Bojan, J. Rooney, Craig Wilson (2017)
Safety and Feasibility of Antiretroviral Preexposure Prophylaxis for Adolescent Men Who Have Sex With Men Aged 15 to 17 Years in the United StatesJAMA Pediatrics, 171
(2017)
Preventing HIV during pregnancy and breastfeeding in the context of PrEP -technical brief. Geneva: World Health Organization
N. Ford, K. Mayer (2015)
World Health Organization Guidelines on Postexposure Prophylaxis for HIV: Recommendations for a Public Health Approach.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 60 Suppl 3
(2018)
verified 1 November 2018
R. Heffron, K. Ngure, J. Odoyo, N. Bulya, E. Tindimwebwa, T. Hong, L. Kidoguchi, D. Donnell, N. Mugo, E. Bukusi, E. Katabira, S. Asiimwe, J. Morton, Susan Morrison, Harald Haugen, A. Mujugira, J. Haberer, N. Ware, Monique Wyatt, M. Marzinke, L. Frenkel, C. Celum, J. Baeten (2017)
Pre-exposure prophylaxis for HIV-negative persons with partners living with HIV: uptake, use, and effectiveness in an open-label demonstration project in East AfricaGates Open Research, 1
(2016)
Truvada PrEP indication approval. London: European Medicines Agency
K. Dehne, G. Dallabetta, D. Wilson, G. Garnett, M. Laga, Elizabeth Benomar, A. Fakoya, R. Baggaley, L. Nelson, S. Kasedde, A. Bermejo, M. Warren, C. Benedikt (2016)
HIV Prevention 2020: a framework for delivery and a call for action.The lancet. HIV, 3 7
decision of PrEP. Canberra: Commonwealth of Australia
L. Bekker, K. Rebe, F. Venter, G. Maartens, Michelle Moorhouse, F. Conradie, C. Wallis, V. Black, B. Harley, R. Eakles (2016)
Southern African guidelines on the safe use of pre-exposure prophylaxis in persons at risk of acquiring HIV-1 infectionSouthern African Journal of HIV Medicine, 17
Prévenir ANRS study group. Incidence of HIV-infection in the ANRS Prévenir study in Paris region with daily or on-demand PrEP with TDF/FTC
(2017)
Prevenir protocol, identifier NCT03113123. Bethesda: US National Library of Medicine
Rockville: United States Food and Drug Administration
R. Evans (2014)
European Centre for Disease Prevention and Control.Nursing standard (Royal College of Nursing (Great Britain) : 1987), 29 9
(2017)
City Health Department; 2017
R. Gandhi (2018)
Preexposure Prophylaxis for the Prevention of HIVNEJM Journal Watch, 2018
Update of BHIVA/BASHH guidelines on the use of HIV pre-exposure prophylaxis (PrEP)
French announcement for PrEP coverage
(2018)
London: HIV i-Base
Brussels: EACS
(2016)
pdf;jsessionid= 83B1BDB16B0097FA7E9E10C35C775C44?sequence=1
(2017)
PrEP impact trial protocol. London: Public Health England
(2016)
Recommendations of the FCSH on pre-exposure prophylaxis (PrEP) for HIV prevention. Bern: Federal Office of Public Health
D. Machado, Alexandre Carvalho, R. Riera (2017)
Adolescent pre-exposure prophylaxis for HIV prevention: current perspectivesAdolescent Health, Medicine and Therapeutics, 8
(2016)
National Policy on HIV Pre-exposure Prophylaxis (PrEP) and Test and Treat (T&T)
R. Grant, D. Glidden (2016)
HIV moments and pre-exposure prophylaxisThe Lancet, 387
(2017)
San Francisco City Health Department. Annual HIV epidemiological report
E. Wright, A. Grulich, Katy Roy, M. Boyd, V. Cornelisse, D. Russell, D. O'Donnell, Bill Whittaker, L. Crooks, I. Zablotska (2018)
Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine HIV pre-exposure prophylaxis: clinical guidelines. Update April 2018Journal of Virus Eradication, 4
A. Ross, R. Ditangco, J. Belimac, R. Olveda, E. Mercado, Thao Chau, S. Crowe (2015)
The dire sexual health crisis among MSM in the Philippines: an exploding HIV epidemic in the absence of essential health services.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 37
(2017)
65 National AIDS & STI Control Programme (NASCOP), Ministry of Health. Framework for the Implementation of Pre-exposure Prophylaxis of HIV in Kenya
V. Fonner, Sarah Dalglish, C. Kennedy, R. Baggaley, K. O'reilly, Florence Koechlin, M. Rodolph, I. Hodges-Mameletzis, R. Grant (2016)
Effectiveness and safety of oral HIV preexposure prophylaxis for all populationsAIDS (London, England), 30
(2018)
GeSIDA) of the Spanish Society of Infectious Diseases and Clinical Microbiology. Consensus document on control and monitoring of HIV infection
(2018)
World Health Organization Postexposure
N. Ford, M. Vitoria, M. Doherty (2018)
Providing antiretroviral therapy to all who are HIV positive: the clinical, public health and programmatic benefits of Treat AllJournal of the International AIDS Society, 21
R. Grant, J. Lama, P. Anderson, V. McMahan, A. Liu, Lorena Vargas, P. Goicochea, M. Casapia, J. Guanira-Carranza, María Ramírez-Cardich, Orlando Montoya-Herrera, T. Fernández, V. Veloso, S. Buchbinder, S. Chariyalertsak, M. Schechter, L. Bekker, K. Mayer, E. Kallás, K. Amico, K. Mulligan, Lane Bushman, Robert Hance, Carmela Ganoza, P. Defechereux, Brian Postle, Furong Wang, J. McConnell, Jia-Hua Zheng, Jean Lee, J. Rooney, H. Jaffe, Ana Martínez, D. Burns, D. Glidden (2010)
Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.The New England journal of medicine, 363 27
R. Coleman, M. Prins (2017)
Options for affordable pre-exposure prophylaxis (PrEP) in national HIV prevention programmes in EuropeEurosurveillance, 22
In September 2015, the World Health Organization (WHO) launched evidence-based guidelines by recommending that any person at substantial HIV risk should be offered oral pre-exposure prophylaxis (PrEP) containing tenofovir disoproxil fumarate (TDF) as an additional prevention choice. Since 2017, PrEP medicines have also been listed in the WHOs Essential Medicines List, including TDF/emtricitabine (FTC) and TDF in combination with lamivudine (3TC). A descriptive policy review and analysis of countries adopting WHOs 2015 recommendation on oral PrEP was conducted. As of June 2018, we identified 35 countries that had some type of policy on oral PrEP, and an additional five countries where a specific policy on PrEP is currently pending. A total of 19 high-income countries (HICs) and 21 low- and middle-income countries (LMICs) have adopted or have a pending policy. Most countries that have adopted or pending PrEP are in the European (42.9%) or African (30.0%) region. TDF/FTC is the most commonly recommended PrEP drug in the guidelines reviewed, although seven countries, namely in sub-Saharan Africa (6/7), are also recommending the use of TDF/3TC for PrEP. In sum, by the end of 2018, at least 40 countries (20.6%) are anticipated to have adopted WHOs oral PrEP recommendation. Nonetheless, policy uptake does not reflect broader programmatic coverage of PrEP services, which remain limited across all settings, irrespective of income status. Enhancing global partnerships is needed to support and track ongoing policy adoption and to ensure that policy is translated into meaningful implementation of PrEP services.
Sexual Health – CSIRO Publishing
Published: Jan 1, 2018
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.